Methods

Study Design
The design and results of the OSTEOPATHIC Trial have been previously published. [10] [11] [12] This double- These 3 techniques were agreed to by the osteopathy, chiropractic, and physiotherapy professional associations in the UK Back pain Exercise And Manipulation (UK BEAM) trial. 13 Additionally, our protocol included myofascial release, counterstrain, and muscle energy techniques, as well as other optional techniques if time permitted. 10 Sham OMT involved hand contact, active and passive range of motion, and techniques that simulated OMT but used such maneuvers as light touch, improper patient positioning, purposely misdirected movements, and diminished provider force. 10 This approach has achieved a robust placebo response 14 compared with other placebo treatments for pain 15 and has been adopted elsewhere. 16 The study protocol was approved by the Institutional Review
Board at the University of North Texas Health Science
Center, and all patients provided written informed consent. The trial was registered with ClinicalTrials .gov (NCT00315120).
spinal manipulation in providing short-term LBP relief. However, the latter was based on very low-quality evidence, including small sample sizes, high risk of bias, and heterogeneity of research design in many included studies. 5 There has been growing interest in targeting subgroups of patients with LBP to identify those most likely to improve with intervention. A clinical prediction rule for spinal manipulation that included 5 patient-reported or practitioner-based measurements showed promising results over 4 weeks in patients with LBP of varying duration. 6 The Keele University Subgroups for Targeted Treatment (STarT) Back Screening
Tool was subsequently validated as a brief instrument for assessing risk of persistence and disability to be used in a stratified approach to managing LBP in primary care. 7 There are no corresponding strategies, VAS scores ranging from 0 mm to 100 mm. This approach was reversed in the highest-to-lowest (HTL) strategy wherein outcomes were determined by cumulative baseline scores ranging from 100 mm to 0 mm. For back-specific functioning, the analyses and plots were based on cumulative baseline RMDQ scores ranging from 0 to 24 (LTH strategy) and from 24 to 0 (HTL strategy). Substantial improvement in back-specific functioning was also defined as a 50% or greater reduction in the RMDQ score vs baseline because this response threshold has been used in multiple trials 8 and was consistent with our threshold for LBP intensity.
Using both relative (RR) and absolute (NNT) outcome metrics provided a robust assessment of OMT response.
Additionally, the current study focused both on improvements in LBP and related functioning that are important to individual patients and on treatment effects at the population level that are important to policy makers and stakeholders.
Statistical Analysis
Data were summarized as median (interquartile range
[IQR]) for continuous variables and as number (%) for categorical variables. Risk ratios and 95% CIs were computed using contingency table methods. The NNTs were computed as the reciprocal of the absolute difference in proportion of substantial improvement with OMT relative to sham OMT and 95% CIs were computed using the Wilson score method. 20 Areas under the curve (down to 0 for percentage of responders and RR, and down to 1 for NNT) and 95% CIs were computed in all analyses. Undefined values of RR or NNT (attributable to small cell sizes and division by 0) were assigned RR=1 (no effect) or NNT=100 (minimal effect). Number-needed-to-treat outcomes greater than 100 or less than 0 were also assigned a score of 100 in computing areas under the curve. and RR>2, large effect. There are no commonly accepted guidelines for interpreting clinical relevance of NNT outcomes because they are sensitive to the level of efficacy of the control group and depend on various study design features, including the outcome measure and how it is dichotomized. 22 Consequently, assessment of the clinical relevance of NNTs was guided by a systematic review of clinical trials wherein oral analgesics were compared with placebo controls using 50% or greater pain reduction as the measure of short-term treatment success. 23 The following guidelines were thus established: NNT≥10, small effect; 5≤NNT<10, medium effect; and 1≤NNT<5, large effect (NNT<0 represents a negative effect or harm). This NNT classification scheme is compatible with the interpretation of RMDQ outcomes in the UK BEAM trial. 24 Finally, multiple logistic regression was used to com- 
Results
Patient Characteristics and Overall Study Results
The baseline patient characteristics of the treatment groups were comparable ( Table 1 The cumulative distribution function for RR demonstrated that the HTL strategy for patient subgrouping yielded significantly better OMT outcomes than the ). The LTH strategy involved computing and plotting the RR for 101 discrete points representing cumulative baseline visual analog scale (VAS) scores from 0 mm to 100 mm, whereas the HTL strategy was based on scores from 100 mm to 0 mm. For back-specific functioning, the analyses and plots were based on 25 discrete points representing cumulative baseline Roland-Morris Disability Questionnaire (RMDQ) scores from 0 to 24 and from 24 to 0 for the respective strategies. The cumulative number of patients at risk is presented below the x-axis for the corresponding strategy. The RR and 95% CI reported in each plot represent the overall results when the 2 strategies converge to include all 455 patients. Patients with baseline scores 10 mm or less or greater than 90 mm on the VAS, or with 2 or less or greater than 21 on the RMDQ, were not included in the plots to avoid extreme or undefined RRs attributable to small sample size. The plots were smoothed by using the moving average of RRs over successive 10-mm intervals of baseline VAS scores and 3-point intervals of baseline RMDQ scores (this smoothing obscured the large treatment effect observed in 186 patients with baseline VAS scores 50 mm or greater). Abbreviations: LBP, low back pain; NAR, number at risk. ). The LTH strategy involved computing and plotting the NNT for 101 discrete points representing cumulative baseline visual analog scale (VAS) scores from 0 mm to 100 mm whereas the HTL strategy was based on scores from 100 mm to 0 mm. For back-specific functioning, the analyses and plots were based on 25 discrete points representing cumulative baseline Roland-Morris Disability Questionnaire (RMDQ) scores from 0 to 24 and from 24 to 0 for the respective strategies. The cumulative number of patients at risk is presented below the x-axis for the corresponding strategy. The NNT and 95% CI reported in each plot represent the overall results when the 2 strategies converge to include all 455 patients. The first and second confidence limits represent the range of best to worst NNT, respectively, with negative values indicating harm. Patients with baseline scores 10 mm or less or greater than 90 mm on the VAS, or with 2 or less or greater than 21 on the RMDQ, were not included in the plots to avoid extreme or undefined NNTs attributable to small sample size. The plots were smoothed by using the moving average of NNTs over successive 10-mm intervals of baseline VAS scores and 3-point intervals of baseline RMDQ scores. Abbreviations: LBP, low back pain; NAR, number at risk. sity that meet the criteria for both substantial improvement and minimally important change. 10 The present responder analysis now indicates that patient subgroups may be targeted for response to OMT according to their baseline levels of LBP intensity and back-specific functioning. Extrapolating to the general population of patients with chronic LBP, our results suggest that sizeable subgroups of patients, perhaps as many as two-thirds, may be targeted for large treatment effects in substantially reducing LBP intensity. Correspondingly, about (ie, minimally important change), including the cumulative distribution functions for RR and NNT and the multivariate analyses for improvement in LBP intensity and back-specific functioning, were generally comparable to those reported herein for substantial improvement.
Discussion
The OSTEOPATHIC Trial has previously shown that OMT is efficacious in achieving reductions in LBP inten- treatment and control groups. 9 The present study demonstrates the feasibility of cumulative distribution func- 
Conclusion
The increasing use of magnetic resonance imaging, opioid prescribing, epidural steroidal injections, and spinal surgery has not improved outcomes or disability rates in patients with chronic LBP. 29 Our results indicate that OMT is more efficacious in treating chronic LBP than previously reported in the latest Cochrane review of spinal manipulation, 5 particularly in patient subgroups that may be easily identified by their baseline levels of LBP intensity. Thus, it appears reasonable to target the patient subgroups identified herein for a short course of OMT before proceeding to such other interventions. Patients with greater LBP intensity may represent an ideal population to target for OMT because they are most likely to accept the risks and costs of more invasive procedures such as lumbar surgery. 30 Additional research may also be warranted to explore how the subgroup findings reported herein may be combined with other subgrouping approaches to more effectively target patients with chronic LBP for treatment.
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for moderate and substantial improvement, respectively, facilitates corroboration of our findings and implementation in clinical practice.
The OSTEOPATHIC Trial is the largest single-site efficacy trial of spinal manipulation for chronic LBP based on a comparison with 26 trials reported in the Cochrane Review, including chiropractic and physical therapy studies. 5 Although focusing on efficacy facilitated tighter control of experimental design, our trial exhibited several pragmatic features that enhance the generalizability of its findings. These included limited exclusion criteria (eg, no thresholds for LBP intensity or back-specific functioning), clinically meaningful outcomes for patients, and intention-to-treat analysis. 26 Moreover, the OMT protocol included the 3 techniques commonly used by chiropractors, foreign-trained osteopaths, and physiotherapists, as agreed to in the UK BEAM trial. 13 The multivariate results and absence of interaction effects further suggest that OMT efficacy may not vary significantly according to such factors as patient demographic characteristics, LBP features, comorbid medical conditions, and use of prescription or nonprescription medication for LBP.
There are several potential limitations of our study.
First, responder analysis was not planned when our trial was initially developed over 10 years ago. These a posteriori subgroup analyses were based on patient characteristics established before randomization. Hence, they are less vulnerable to biases than analyses based on variables derived after randomization. Nevertheless, it is possible that confounding variables may no longer have been distributed at random in the subgroups, 27 particularly in those with smaller numbers of patients at risk. Second, we used the last-observation-carried-forward to impute missing data. While other methods for data imputation have been used in the OSTEOPATHIC Trial, they have not yielded materially different results. 10, 28 Third, the NNT is not widely used and reported as a measure of efficacy and, unlike the RR, there are no established guidelines for its interpretation in LBP research. 21 
